How do deep vein thrombosis (DVT) and peripheral arterial disease (PAD) differ in anatomy, pathophysiology, clinical presentation, risk factors, diagnostic work‑up, and management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

DVT vs PAD: Key Clinical Distinctions

Fundamental Pathophysiology

Deep vein thrombosis (DVT) and peripheral arterial disease (PAD) are fundamentally opposite vascular disorders: DVT is a venous thrombotic disease caused by blood clot formation in deep veins, while PAD is an arterial occlusive disease caused by atherosclerotic stenosis of arteries. 1, 2, 3

DVT Pathophysiology

  • DVT results from thrombus formation in deep veins (commonly calf, femoral, popliteal, or pelvic veins) following Virchow's Triad: venous stasis, vascular injury, and hypercoagulability 2, 3
  • The venous system is affected, with blood clots obstructing venous return and causing proximal congestion 2
  • Affects approximately 0.1% of persons per year, predominantly elderly with slight male preponderance 2

PAD Pathophysiology

  • PAD is caused by progressive atherosclerotic occlusion of lower-extremity arteries, most commonly the superficial femoral and popliteal arteries 4
  • The arterial system is affected, with stenotic lesions reducing blood flow and oxygen delivery to distal tissues 1, 4
  • Affects 8-12 million adults in the United States, with prevalence rising to approximately 29% in those aged ≥70 years 5

Anatomic Distribution

DVT Anatomy

  • Involves the venous system: deep leg veins (calf veins, femoral vein, popliteal vein) or deep pelvic veins 2
  • Left leg involvement occurs in 55% of cases, right leg in 37%, and bilateral in 8% 6
  • Common femoral vein (48.5%), popliteal vein (72%), and posterior tibial veins (71%) are most frequently affected 6

PAD Anatomy

  • Involves the arterial system: infradiaphragmatic arteries including abdominal aorta, renal arteries, mesenteric arteries, and lower-extremity arteries 1, 5
  • Femoral-popliteal disease produces isolated calf pain; iliac disease causes hip, buttock, and thigh pain; tibial disease may cause foot pain 4

Clinical Presentation

DVT Clinical Features

  • Unilateral leg swelling and edema (hallmark finding) 2, 7
  • Calf pain, tenderness, and warmth 2, 8
  • Dilatation of superficial veins 8
  • Whole limb enlargement or one-sided calf enlargement 8
  • Symptoms are typically acute in onset 3
  • Edema is present and prominent 7

PAD Clinical Features

  • Intermittent claudication: exercise-induced pain relieved by rest (most common symptomatic presentation) 1, 4
  • Anatomic correlation: calf pain with femoral-popliteal disease; buttock/thigh pain with iliac disease 4
  • Critical limb ischemia: rest pain (worse supine, relieved by dependency), non-healing ulcers, gangrene 1, 4
  • Absence of edema is characteristic (edema suggests alternative diagnosis) 5
  • Physical findings: diminished/absent pulses, cool skin, pallor on elevation, trophic changes, hair loss, hypertrophic nails 1, 5
  • Up to 50% of PAD patients are asymptomatic 5

Risk Factors

DVT Risk Factors

  • Immobilization, confinement to bed 8
  • Recent major surgery 8
  • Active malignancy (16% of cases) 6
  • Prior VTE 8
  • Obesity (47% of cases), diabetes mellitus (28%) 6
  • Hypercoagulable states: abnormal protein C (9%), protein S (7%), factor V Leiden (3.8%), antithrombin III deficiency (4%) 6

PAD Risk Factors

  • Cigarette smoking (strongest modifiable risk factor) 1, 4
  • Diabetes mellitus 1, 4
  • Dyslipidemia 1, 4
  • Hypertension 1, 4
  • Hyperhomocysteinemia 1, 4
  • Age ≥70 years or age 50-69 with diabetes/smoking history 5

Diagnostic Work-Up

DVT Diagnosis

  • Clinical prediction rules: Wells score or Geneva score to assess pre-test probability 8
  • D-dimer testing: elevated in DVT but non-specific 2
  • Compression ultrasonography (Doppler ultrasound): gold standard diagnostic test showing non-compressible veins with thrombus 2, 6
  • Algorithm: pre-test probability assessment → D-dimer if low/moderate probability → compression ultrasound for confirmation 2

PAD Diagnosis

  • Ankle-brachial index (ABI): initial non-invasive test; ABI ≤0.90 confirms PAD 1, 9
  • Post-exercise ABI if resting ABI >0.90 with clinical suspicion; >20% decrease diagnostic 1
  • Toe-brachial index (TBI) and transcutaneous oxygen pressure (TcPO₂) in diabetics with calcified vessels (falsely elevated ABI) 1, 9
  • Duplex Doppler ultrasound to evaluate arterial anatomy and stenosis severity 9
  • Vascular physical examination: pulse palpation (brachial, radial, femoral, popliteal, dorsalis pedis, posterior tibial), femoral bruits, skin changes 1, 4

Management

DVT Management

  • Anticoagulation is the mainstay of treatment to prevent thrombus extension, pulmonary embolism, recurrence, and post-thrombotic syndrome 2, 3
  • Direct oral anticoagulants (DOACs): dabigatran (direct thrombin inhibitor), rivaroxaban and apixaban (factor Xa inhibitors) are now preferred over warfarin in most cases 2, 3
  • Traditional therapy: low-molecular-weight heparin or unfractionated heparin bridging to warfarin 2, 3
  • Thrombolytics and vena caval filters reserved for special circumstances 2
  • Mechanical prophylaxis (compression devices) and pharmacological prophylaxis in high-risk patients 2

PAD Management

  • Cardiovascular risk reduction is the primary therapeutic priority due to systemic atherosclerosis and markedly increased risk of MI, stroke, and CV death 5, 9
  • Antiplatelet therapy (aspirin or clopidogrel) 9
  • High-intensity statin therapy targeting LDL <55 mg/dL 9
  • Blood pressure control to <140/90 mmHg 9
  • Smoking cessation (mandatory) 1
  • Supervised exercise therapy for claudication 1
  • Revascularization (endovascular or surgical) for critical limb ischemia or lifestyle-limiting claudication 1
  • Compression therapy is contraindicated in PAD: absolute contraindication if ABI <0.6; reduced compression (20-30 mmHg) only if ABI 0.6-0.9 9

Critical Diagnostic Pitfall

The presence of edema is the key clinical discriminator: DVT presents with prominent unilateral edema, while PAD characteristically has no edema. 5, 7 If a patient with suspected PAD has edema, evaluate for venous disease, heart failure, renal disease, or other systemic causes rather than attributing it to arterial insufficiency 5. One case report documented DVT mimicking PAD with calf pain, but the presence of edema should have immediately suggested venous rather than arterial pathology 7.


Prognostic Outcomes

DVT Outcomes

  • Pulmonary embolism occurs in 12.2% of cases 6
  • Post-thrombotic syndrome develops in 50% 6
  • Mortality rate of 15% during follow-up, with age >50 years conferring 6.54-fold increased death risk 6

PAD Outcomes

  • 4-5 times increased risk of cardiovascular events (MI, stroke, CV death) compared to patients without PAD 1
  • Major adverse limb events (MALE): amputation, chronic/acute limb ischemia, need for revascularization 1
  • Cardiovascular ischemic events are more frequent than limb events in any PAD cohort 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Deep vein thrombosis: a clinical review.

Journal of blood medicine, 2011

Research

Deep vein thrombosis: pathogenesis, diagnosis, and medical management.

Cardiovascular diagnosis and therapy, 2017

Guideline

Pathophysiology and Clinical Features of Peripheral Arterial Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Peripheral Artery Disease and Edema

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Clinical presentation of deep vein thrombosis and pulmonary embolism.

Best practice & research. Clinical haematology, 2012

Guideline

Peripheral Artery Disease Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.